Cisplatin-related immune responses promote the secretion of cytokines such as IFN-β and IL-6 in vitro and can recruit CD8+ T cells and dendritic cell (DC) infiltration in a mouse tumor microenvironment. Here, CD8A is linked to neoplasm.